These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12968600)

  • 1. [Is it expendient to prescribe ACE inhibitors in stable ischemic heart disease?].
    Makolkin VI
    Kardiologiia; 2003; 43(4):27-9. PubMed ID: 12968600
    [No Abstract]   [Full Text] [Related]  

  • 2. [Angiotensin-converting enzyme inhibitors and chronic ischemic heart disease--new indications?].
    Haghfelt T; Haghfelt A
    Ugeskr Laeger; 2004 Jan; 166(3):169-70. PubMed ID: 14870648
    [No Abstract]   [Full Text] [Related]  

  • 3. [Angiotensin converting enzyme inhibitors and treatment of stable ischemic heart disease: afterword for the European Society of Cardiology recommendations].
    Karpov IuA
    Kardiologiia; 2007; 47(9):34-40. PubMed ID: 18260926
    [No Abstract]   [Full Text] [Related]  

  • 4. Adding ACE inhibitors or ARBs to standard therapy for stable ischemic heart disease.
    Guirguis-Blake J
    Am Fam Physician; 2012 Jul; 86(1):21-3. PubMed ID: 22962909
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ischemic heart disease with low risk of vascular complications -- a novel indication for angiotensin converting enzyme inhibitors (results of EUROPA trial)].
    Perepech NB
    Kardiologiia; 2004; 44(3):106-10. PubMed ID: 15489840
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritization.
    Crowley MJ; Powers BJ; Myers ER; McBroom AJ; Sanders GD
    Am Heart J; 2012 May; 163(5):777-782.e8. PubMed ID: 22607854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors.
    Juggi JS; Koenig-Berard E; Van Gilst WH
    Can J Cardiol; 1993 May; 9(4):336-52. PubMed ID: 8513428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is a combination of verapamil and an ACE-inhibitor the optimal solution in ischaemic heart failure?
    Jespersen CM
    Cardiologia; 1995 Dec; 40(12 Suppl 1):307-10. PubMed ID: 8903054
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acetylsalicylic acid and ACE inhibitors in heart disease--a phenomenon in dogs and cats?].
    Bĕlohlávek J; Aschermann M
    Vnitr Lek; 2002 Aug; 48(8):695-7. PubMed ID: 12425197
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention].
    Ceconi C; Mastrorilli F; Squasi PA; Gaitani S; Guardigli G; Ferrari R
    Ital Heart J; 2005 Nov; 6 Suppl 7():5S-13S. PubMed ID: 16485512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE inhibitors and ischemic heart disease.
    Young JB
    Coron Artery Dis; 1995 Apr; 6(4):272-80. PubMed ID: 7655709
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-ischemic properties of ACE-inhibitors.
    Deedwania PC
    Cardiologia; 1996 Mar; 41(3):209-15. PubMed ID: 8697478
    [No Abstract]   [Full Text] [Related]  

  • 13. What does ATLAS really tell us about "high" dose angiotensin-converting enzyme inhibition in heart failure?
    Nicklas JM; Cohn JN; Pitt B
    J Card Fail; 2000 Jun; 6(2):165-8. PubMed ID: 10908091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The anti-ischemic effects of ACE inhibitors after an acute myocardial infarct].
    Rutherford JD
    Rev Clin Esp; 1996 Dec; 196(4 Monografico):41-2. PubMed ID: 9139332
    [No Abstract]   [Full Text] [Related]  

  • 15. [Suppression of angiotensin-converting enzyme and myocardial ischemia].
    Eliseev OM
    Ter Arkh; 1999; 71(3):73-6. PubMed ID: 10234773
    [No Abstract]   [Full Text] [Related]  

  • 16. Benefit of revascularization for stable ischaemic heart disease: the jury is still out.
    Fassa AA; Wijns W; Kolh P; Steg PG
    Eur Heart J; 2013 Jun; 34(21):1534-8. PubMed ID: 23360779
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential role of angiotensin-converting enzyme inhibition in myocardial ischemia and current clinical trials.
    Pepine CJ
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-58-64. PubMed ID: 9422854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of myocardial ischemia therapy: calcium antagonists and ACE-inhibitors].
    Ferrari R
    Cardiologia; 1994 Dec; 39(12 Suppl 1):203-6. PubMed ID: 7634268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.
    Benedetto U; Melina G; Capuano F; Comito C; Bianchini R; Simon C; Refice S; Angeloni E; Sinatra R
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1098-103. PubMed ID: 18852580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure.
    Kazi D; Deswal A
    Cardiol Clin; 2008 Feb; 26(1):1-14, v. PubMed ID: 18312901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.